02888516 1.10.11 30.9.12 30.9.12 Company accounts Private Limited Company FY true false true false true true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure028885162011-09-30028885162012-09-30028885162011-10-012012-09-30028885162010-09-30028885162010-10-012011-09-30028885162011-09-3002888516ns12:England2011-10-012012-09-3002888516ns14:PoundSterling2011-10-012012-09-3002888516ns7:Director12011-10-012012-09-3002888516ns7:OrdinaryShareClass12011-10-012012-09-3002888516ns7:Director22011-10-012012-09-3002888516ns7:CompanySecretary2011-10-012012-09-3002888516ns7:RegisteredOffice2011-10-012012-09-3002888516ns7:EntityAccountantsOrAuditors2011-10-012012-09-3002888516ns5:PlantMachinery2011-10-012012-09-3002888516ns5:FixedAssetInvestmentsOtherThanLoans2012-09-3002888516ns5:FixedAssetInvestmentsOtherThanLoans2011-09-3002888516ns7:OrdinaryShareClass12012-09-3002888516ns7:OrdinaryShareClass12011-09-30
REGISTERED NUMBER: 02888516 (England and Wales)












ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2012

FOR

AGTC BIOPRODUCTS LIMITED

AGTC BIOPRODUCTS LIMITED (REGISTERED NUMBER: 02888516)






CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 SEPTEMBER 2012




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Report of the Accountants 6

AGTC BIOPRODUCTS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2012







DIRECTORS: R J Russell
N Henderson





SECRETARY: N Henderson





REGISTERED OFFICE: Unit 4
Fleet Business Park
Hessle
E R Yorkshire
HU13 9LX





REGISTERED NUMBER: 02888516 (England and Wales)





ACCOUNTANTS: Humber Business Services
4 Northgate
Hessle
East Yorks of Yorks
HU13 9AA

AGTC BIOPRODUCTS LIMITED (REGISTERED NUMBER: 02888516)

ABBREVIATED BALANCE SHEET
30 SEPTEMBER 2012

2012 2011
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 7,719 5,321
Investments 3 1 1
7,720 5,322

CURRENT ASSETS
Stocks 142,759 116,881
Debtors 371,038 363,028
Cash at bank - 13,689
513,797 493,598
CREDITORS
Amounts falling due within one year 520,736 496,072
NET CURRENT LIABILITIES (6,939 ) (2,474 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

781

2,848

PROVISIONS FOR LIABILITIES 183 -
NET ASSETS 598 2,848

CAPITAL AND RESERVES
Called up share capital 4 98 98
Profit and loss account 500 2,750
SHAREHOLDERS' FUNDS 598 2,848

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2012.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2012 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

AGTC BIOPRODUCTS LIMITED (REGISTERED NUMBER: 02888516)

ABBREVIATED BALANCE SHEET - continued
30 SEPTEMBER 2012


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 28 June 2013 and were signed on its behalf by:





R J Russell - Director


AGTC BIOPRODUCTS LIMITED (REGISTERED NUMBER: 02888516)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 SEPTEMBER 2012

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - over 4 yrs

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at
the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 October 2011 43,705
Additions 6,888
At 30 September 2012 50,593
DEPRECIATION
At 1 October 2011 38,384
Charge for year 4,490
At 30 September 2012 42,874
NET BOOK VALUE
At 30 September 2012 7,719
At 30 September 2011 5,321

AGTC BIOPRODUCTS LIMITED (REGISTERED NUMBER: 02888516)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2012

3. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 October 2011
and 30 September 2012 1
NET BOOK VALUE
At 30 September 2012 1
At 30 September 2011 1

The company's investments at the balance sheet date in the share capital of companies include the following:

Associated company

The company owns 50% of the shares in AGTC Bioproducts LLC and company incorporated in the United
States of America the cost value of these shares was £1.

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2012 2011
value: £    £   
98 Ordinary £1 98 98

5. TRANSACTIONS WITH DIRECTORS

At the 30th September 2012 an amount of £4,300 was owed to the company by the director Mr B Russell, the
company charged interest on the amount at 4%.

AGTC BIOPRODUCTS LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTORS OF
AGTC BIOPRODUCTS LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's annual
unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to five)
have been prepared.

As described on the balance sheet you are responsible for the preparation of the financial statements for the year ended
30 September 2012 set out on pages nil to nil and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to
fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Humber Business Services
4 Northgate
Hessle
East Yorks of Yorks
HU13 9AA


28 June 2013